Oncology & Cancer

Lung cancer risk model refines decisions to screen

A new method for determining lung cancer risk could more efficiently identify individuals for annual screening and catch more cancers early, according to a study published in this week's PLOS Medicine. The study, conducted ...

Oncology & Cancer

Tumor-associated neutrophils boost anti-tumor immune responses

Lung cancer is a leading cause of cancer-related deaths in both men and women, and survival depends on the stage of cancer at diagnosis. An inflammatory response is induced following tumor formation, and the immune cells ...

Oncology & Cancer

Lung cancer screening with low-dose CT could be cost effective

Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine. ...

Oncology & Cancer

Researchers reveal genomic diversity of individual lung tumors

Known cancer-driving genomic aberrations in localized lung cancer appear to be so consistently present across tumors that a single biopsy of one region of the tumor is likely to identify most of them, according to a paper ...

Oncology & Cancer

Crizotinib treatment effective against ROS1-positive lung cancer

Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene. In an article receiving Online First publication in the New England Journal of Medicine ...

Oncology & Cancer

Researchers use infrared imaging to detect lung tumors

Penn Medicine researchers are now able to identify cancerous tumors of the lung using infrared imaging that makes hidden tumors glow during surgery. In a pilot study, researchers performed the first in-human demonstration ...

page 18 from 22